Metraipolis › archive › dc_655ae3f45d3e

Elucidating Trigonelline's Therapeutic Mechanisms for Traumatic Brain Injury Through Integrated Network Pharmacology and In Vivo Validation — Europe PMC PMID:41801080

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41801080
DOI
10.1002/cns.70803
License (as archived)
solo-consultazione
Archived
2026-10-08T09:14:13.678Z
SHA-256 of the archived text
dfd978204ed6e1192dacf1353c765a770ba588e9c29df1a4494bd1afdc8777de
Stable URL of this page
https://metraipolis.com/documento/dc_655ae3f45d3e

How to cite

Elucidating Trigonelline's Therapeutic Mechanisms for Traumatic Brain Injury Through Integrated Network Pharmacology and In Vivo Validation — Europe PMC PMID:41801080 — Europe PMC (en), https://europepmc.org/article/MED/41801080 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_655ae3f45d3e (Metraipolis archive dc_655ae3f45d3e, sha256 dfd978204ed6e1192dacf1353c765a770ba588e9c29df1a4494bd1afdc8777de)
BibTeX
@misc{dc655ae3f45d3e,
  title = {Elucidating Trigonelline's Therapeutic Mechanisms for Traumatic Brain Injury Through Integrated Network Pharmacology and In Vivo Validation — Europe PMC PMID:41801080},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41801080},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_655ae3f45d3e; sha256 dfd978204ed6e1192dacf1353c765a770ba588e9c29df1a4494bd1afdc8777de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41801080. Agents can read the archived copy with the MCP tool read_document.